416 related articles for article (PubMed ID: 10713672)
1. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
5. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
6. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
7. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
Nass SJ; Dickson RB
Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
[TBL] [Abstract][Full Text] [Related]
12. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
[TBL] [Abstract][Full Text] [Related]
13. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
14. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.
Chepko G; Slack R; Carbott D; Khan S; Steadman L; Dickson RB
Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731
[TBL] [Abstract][Full Text] [Related]
15. The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells.
DeMuth JP; Jackson CM; Weaver DA; Crawford EL; Durzinsky DS; Durham SJ; Zaher A; Phillips ER; Khuder SA; Willey JC
Am J Respir Cell Mol Biol; 1998 Jul; 19(1):18-24. PubMed ID: 9651176
[TBL] [Abstract][Full Text] [Related]
16. p27kip1-independent cell cycle regulation by MYC.
Berns K; Martins C; Dannenberg JH; Berns A; te Riele H; Bernards R
Oncogene; 2000 Oct; 19(42):4822-7. PubMed ID: 11039898
[TBL] [Abstract][Full Text] [Related]
17. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases.
Pusch O; Bernaschek G; Eilers M; Hengstschläger M
Oncogene; 1997 Aug; 15(6):649-56. PubMed ID: 9264405
[TBL] [Abstract][Full Text] [Related]
18. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
Simile MM; De Miglio MR; Muroni MR; Frau M; Asara G; Serra S; Muntoni MD; Seddaiu MA; Daino L; Feo F; Pascale RM
Carcinogenesis; 2004 Mar; 25(3):333-41. PubMed ID: 14604889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]